The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Hepatology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jhep.2012.06.021PMID 22732512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C Virus Infection Promotes Hepatic Gluconeogenesis through an NS5A-Mediated, FoxO1-Dependent Pathway

  2011cited by this paper
• Manifestations of chronic hepatitis C virus infection beyond the liver.

  2010cited by this paper
• Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma

  2009cited by this paper
• Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

  2009cited by this paper
• Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.

  2008cited by this paper
• Impact of Oxidative Stress and Peroxisome Proliferator–Activated Receptor γ Coactivator-1α in Hepatic Insulin Resistance

  2008cited by this paper
• Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

  2008cited by this paper
• Hepatitis C Virus Core Protein Upregulates Serine Phosphorylation of Insulin Receptor Substrate-1 and Impairs the Downstream Akt/Protein Kinase B Signaling Pathway for Insulin Resistance

  2007cited by this paper
• The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype‐specific mechanisms

  2007cited by this paper
• Mecanismos de lesión hepatocelular

  2007cited by this paper
• Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein.

  2007cited by this paper
• Clearance of HCV Improves Insulin Resistance, Beta-Cell Function, and Hepatic Expression of Insulin Receptor Substrate 1 and 2

  2007cited by this paper
• A Rab-GAP TBC Domain Protein Binds Hepatitis C Virus NS5A and Mediates Viral Replication

  2007cited by this paper
• Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response

  2006cited by this paper
• Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

  2006cited by this paper
• Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.

  2006cited by this paper
• Reactive oxygen species have a causal role in multiple forms of insulin resistance

  2006cited by this paper
• PGC-1alpha controls hepatitis B virus through nutritional signals.

  2006cited by this paper
• Oxidative metabolism in cancer growth

  2006cited by this paper
• PGC-1α controls hepatitis B virus through nutritional signals

  2006cited by this paper
• Involvement of the PA28γ-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein

  2006cited by this paper
• TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.

  2005cited by this paper
• TNF-α, chronic hepatitis C and diabetes: a novel triad

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

  2005cited by this paper
• Metabolic control through the PGC-1 family of transcription coactivators.

  2005cited by this paper
• Complete Replication of Hepatitis C Virus in Cell Culture

  2005cited by this paper
• Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.

  2004cited by this paper
• Impaired IRS‐1/PI3‐kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes

  2003cited by this paper
• Mechanisms of increased insulin resistance in non‐cirrhotic patients with chronic hepatitis C virus infection

  2003cited by this paper
• Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis

  2003cited by this paper
• Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction

  2003cited by this paper
• Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.

  2003cited by this paper
• An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle.

  2003cited by this paper
• Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

  2003cited by this paper
• An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle

  2003cited by this paper
• Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

  2001influential reference
• Hepatitis C virus infection.

  2001cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000influential reference
• Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection.

  2000cited by this paper
• A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.

  1998cited by this paper
• Erratum: Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases (Modern Pathology (1998) 11 (65-71))

  1998cited by this paper
• Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases.

  1998cited by this paper
• Glucose-6-Phosphatase Structure, Regulation, and Function: An Update 1

  1997cited by this paper
• On respiratory impairment in cancer cells.

  1956cited by this paper

• Single-cell atlas of hepatitis C virus inoculated tree shrew liver reveals immune activation, metabolic reprogramming, and persistent inflammation

  2025cites this paper
• The hidden RNA code: implications of the RNA epitranscriptome in the context of viral infections

  2023cites this paper
• Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention

  2023cites this paper
• Moonlighting Effects of Pyruvate Kinase M2 in Chronic Liver Diseases

  2023cites this paper
• Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

  2022cites this paper
• LncRNA KCNQ1OT1 promoted hepatitis C virus-induced pyroptosis of β-cell through mediating the miR-223-3p/NLRP3 axis

  2021cites this paper
• Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders

  2021cites this paper
• The Roles of Host 5-Methylcytosine RNA Methyltransferases during Viral Infections

  2020cites this paper
• GCN5 ACETYLTRANSFERASE IN CELLULAR ENERGETIC AND METABOLIC PROCESSES.

  2020cites this paper
• Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients

  2020cites this paper
• Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism

  2019cites this paper
• Visfatin serum concentration and hepatic mRNA expression in chronic hepatitis C

  2019cites this paper
• PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments

  2019cites this paper
• Effect of PPARGC1A on the development and metabolism of early rabbit embryos in vitro

  2019cites this paper
• Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis

  2019cites this paper
• Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis

  2017cites this paper
• Quantitative evaluation of insulin resistance markers in Pakistani patients suffering from HCV-associated type 2 diabetes mellitus.

  2017cites this paper
• Systemic manifestations of hepatitis C infection

  2016cites this paper
• HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis

  2016cites this paper
• PGC-1α, glucose metabolism and type 2 diabetes mellitus.

  2016cites this paper
• Metabolic alterations and hepatitis C: From bench to bedside.

  2016cites this paper
• Role of Kynurenine Pathway in Insulin Resistance: Toward Kynurenine Hypothesis of Insulin Resistance and Diabetes

  2015cites this paper
• Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM

  2015cites this paper
• Targeting the Broadly Pathogenic Kynurenine Pathway

  2015cites this paper
• Hepatitis C virus infection, metabolic disorders and non-alcoholic fatty liver disease: a literature review.

  2015cites this paper
• Endoplasmic Reticulum Stress Links Hepatitis C Virus RNA Replication to Wild-Type PGC-1α/Liver-Specific PGC-1α Upregulation

  2014influential citation
• Investigating the antiviral role of cell death‐inducing DFF45‐like effector B in HCV replication

  2014cites this paper
• Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1

  2014cites this paper
• Mitochondrial reactive oxygen species as a mystery voice in hepatitis C

  2014cites this paper
• Tryptophan-Kynurenine Metabolism and Insulin Resistance in Hepatitis C Patients

  2013cites this paper
• Hepatocyte Nuclear Factor 4 (cid:2) and Downstream Secreted Phospholipase A 2 GXIIB Regulate Production of Infectious Hepatitis C Virus

  2013cites this paper
• HCV and Oxidative Stress in the Liver

  2013cites this paper